The Canadian Agency for Drugs and Technologies in Health and the United Kingdom’s National Institute for Health and Care Excellence (NICE) have recommended against public-payer adoption of intranasal esketamine.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (3)

• United Kingdom location
• esketamine concept
• National Institute for Health and Care Excellence entity